T cell-dependent ADA production is thought to be the major pathway through which TPP induce immunogenicity as in the case of IgG1 and IgG4 generated against anti-TNFα mAb to treat a variety of inflammatory and autoimmune diseases [7]. This evidence concerns the gene TNF and autoimmune disease.